Please use this identifier to cite or link to this item: http://sgc.anlis.gob.ar/handle/123456789/1765
Title: Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study
Authors: Colantonio, Lisandro D 
Prado, Nilda Graciela 
Segura, Elsa L. 
Sosa-Estani, Sergio 
Keywords: Adolescente;Argentina;Cardiomiopatía Chagásica;Niño;Estudios de Cohortes;Método Doble Ciego;Humanos;Nitroimidazoles;Estudios Retrospectivos;Tripanocidas;Electrocardiografía;Trypanosoma cruzi
Issue Date: 9-May-2016
Publisher: Public Library of Science
Project: datasets
Journal: PLoS neglected tropical diseases 
Abstract: 
Background: Chronic infection by Trypanosoma cruzi could cause heart conduction disturbances. We sought to analyze electrocardiographic abnormalities among children with chronic T. cruzi infection with and without trypanocidal treatment with benznidazole.

Methodology/principal findings: We studied 111 children 6-16 years of age with asymptomatic chronic T. cruzi infection who were recruited in 1991-1992 in Salta, Argentina. Most children were randomly assigned to benznidazole 5 mg/Kg/day (n = 47) or matching placebo (n = 48) for 60 days. Remaining children (n = 16) received treatment with benznidazole 5 mg/Kg/day open-label. Electrocardiograms were obtained at baseline and in 1995-1996, 1998, 2000 and 2005, and were analyzed using the Buenos Aires method. Among the 94 children with an electrocardiogram at baseline, 8 (8.5%) had electrocardiographic abnormalities, including 4 (4.7%) children with right bundle branch block. Proportion of abnormal electrocardiograms in the full population (n = 111) remained constant over time (media follow-up 8.6 years). Multivariable adjusted prevalence ratios (95% confidence interval [95%CI]) for electrocardiographic abnormalities in 1995-1996, 1998, 2000 and 2005 comparing children treated with benznidazole versus those not treated were 2.76 (0.66, 11.60), 2.33 (0.44, 12.31), 3.06 (0.48, 19.56), and 1.94 (0.33, 11.25), respectively. Among the 86 children with a normal electrocardiogram at baseline, 16 (18.6%) developed electrocardiographic abnormalities during follow-up. The multivariable adjusted hazard ratio for incident electrocardiographic abnormalities comparing children treated with benznidazole versus those not treated was 0.68 (95%CI: 0.25, 1.88).

Conclusions/significance: Electrocardiographic abnormalities are frequent among children with chronic T. cruzi infection. Treatment with benznidazole for 60 days may not be associated with less electrocardiographic abnormalities.
Description: 
Fil: Colantonio, Lisandro D. University of Alabama at Birmingham. School of Public Health. Department of Epidemiology; Estados Unidos.

Fil: Prado, Nilda. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Parasitología; Argentina.

Fil: Segura, Elsa L. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Parasitología; Argentina.

Fil: Sosa-Estani, Sergio. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Parasitología; Argentina.
URI: http://sgc.anlis.gob.ar/handle/123456789/1765
DOI: 10.1371/journal.pntd.0004651
Rights: Open Access
Appears in Collections:Publicaciones INP

Files in This Item:
File Description SizeFormat
PLoS Neglected Tropical Deseases_2016_10(5).pdfArtículo en inglés357.44 kBAdobe PDFView/Open
Show full item record

Page view(s)

85
checked on Apr 25, 2024

Download(s)

6
checked on Apr 25, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons